Page 2 - தேசிய நிறுவனம் ஆன் சிறுபான்மை ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Is Depression More Pronounced in Certain Racial and Ethnic Groups?
thyblackman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thyblackman.com Daily Mail and Mail on Sunday newspapers.
The Triple Aim for Payment Reform in Joint Replacement Surgery
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.
Alston & Bird Health Care Week In Review, July 16, 2021 - Food, Drugs, Healthcare, Life Sciences
mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Andrea Gilmore-Bykovskyi, PhD, RN
(UW Center for Health Disparities Research and UW School of Nursing) is recognize by the American Federation for Aging Research (AFAR) with the 2021 Terrie Fox. view more
Credit: image courtesy of UW Medicine
New York, NY - The American Federation for Aging Research (AFAR), a national non-profit organization whose mission is to support and advance healthy aging through biomedical research, is proud to recognize the outstanding contributions of Andrea Gilmore-Bykovskyi, PhD, RN, with the 2021 Terrie Fox Wetle Rising Star Award in Health Services and Aging Research.
This award honors a health services researcher in an early or middle phase of his/her career who has already made important contributions with work that respects the value of multidisciplinary health services science and that is likely to be highly influential in shaping practice and research for decades to come.
By oracknows on August 16, 2015.
The approval of new drugs and medical devices is a process fraught with scientific, political, and ethical landmines. Inherent in any such process is an unavoidable conflict between rigorous science and safety on the one side, which tend to slow the process down by requiring large randomized clinical trials that can take years, versus forces that demand faster approval. For example, patients suffering from deadly diseases demand faster approval of drugs that might give them the hope of surviving their disease, or at least of surviving considerably longer. This is a powerful force for reform, as evidenced by HIV/AIDS activism in the 1980s and 1990s that led to the development of fast-track approval mechanisms for drugs for life-threatening conditions, a change whose effects have been mixed. It s also a powerful force potentially for ill, as I ve documented in my posts about the understandable but misguided right-to-try movement. Af